Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice.

Yokoyama S, Kitamoto S, Higashi M, Goto Y, Hara T, Ikebe D, Yamaguchi T, Arisaka Y, Niihara T, Nishimata H, Tanaka S, Takaori K, Batra SK, Yonezawa S.

PLoS One. 2014 Apr 8;9(4):e93760. doi: 10.1371/journal.pone.0093760. eCollection 2014.

2.

Significance of mucin expression in pancreatobiliary neoplasms.

Yonezawa S, Higashi M, Yamada N, Yokoyama S, Goto M.

J Hepatobiliary Pancreat Sci. 2010 Mar;17(2):108-24. doi: 10.1007/s00534-009-0174-7. Epub 2009 Sep 29. Review.

PMID:
19787286
3.

Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ.

Ann Surg Oncol. 2011 Jan;18(1):199-206. doi: 10.1245/s10434-010-1225-7. Epub 2010 Aug 18.

4.

Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.

Ann Surg. 2013 Jul;258(1):141-51. doi: 10.1097/SLA.0b013e31828cd008.

PMID:
23532108
5.

MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.

Shimamoto T, Tani M, Kawai M, Hirono S, Ina S, Miyazawa M, Shimizu A, Uchiyama K, Yokoyama S, Tsutsumi M, Yamaue H.

Pancreas. 2010 Aug;39(6):879-83. doi: 10.1097/MPA.0b013e3181d6ba04.

PMID:
20357691
6.

Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.

Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF.

J Pathol. 2002 Aug;197(5):632-7.

PMID:
12210083
7.

Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Yamaguchi J, Mino-Kenudson M, Liss AS, Chowdhury S, Wang TC, Fernández-Del Castillo C, Lillemoe KD, Warshaw AL, Thayer SP.

Gastroenterology. 2016 Dec;151(6):1232-1244.e10. doi: 10.1053/j.gastro.2016.07.045. Epub 2016 Aug 12.

PMID:
27523981
8.

Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.

Aso T, Ohtsuka T, Tamura K, Ideno N, Kono H, Nagayoshi Y, Ohuchida K, Ueda J, Takahata S, Shindo K, Aishima S, Oda Y, Mizumoto K, Tanaka M.

Pancreas. 2014 Apr;43(3):361-6. doi: 10.1097/MPA.0000000000000042.

PMID:
24622064
9.

Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior.

Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M.

Proteomics. 2008 Aug;8(16):3329-41. doi: 10.1002/pmic.200800040. Review.

PMID:
18651706
10.

The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Yonezawa S, Nakamura A, Horinouchi M, Sato E.

J Hepatobiliary Pancreat Surg. 2002;9(3):328-41.

PMID:
12353144
11.

Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.

Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH, Klimstra DS.

Am J Surg Pathol. 2004 Jul;28(7):839-48.

PMID:
15223952
12.

Mucin expression profile in pancreatic cancer and the precursor lesions.

Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, Yonezawa S.

J Hepatobiliary Pancreat Surg. 2007;14(3):243-54. Epub 2007 May 29. Review.

PMID:
17520199
13.
14.

Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.

Tamura K, Ohtsuka T, Date K, Fujimoto T, Matsunaga T, Kimura H, Watanabe Y, Miyazaki T, Ohuchida K, Takahata S, Ishigami K, Oda Y, Mizumoto K, Nakamura M, Tanaka M.

Pancreas. 2016 Jul;45(6):826-35. doi: 10.1097/MPA.0000000000000563.

PMID:
26646266
15.

MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.

Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.

Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.

PMID:
24280573
17.

[Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].

Ji Y, Tan YS, Zhu XZ, Zeng HY, Kuang TT, Jin DY.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):77-81. Chinese.

PMID:
16630480
18.

Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.

Sierzega M, Młynarski D, Tomaszewska R, Kulig J.

Histopathology. 2016 Oct;69(4):582-91. doi: 10.1111/his.12994. Epub 2016 Jun 23.

PMID:
27165582
19.

MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.

Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D, Siegal GP, Grizzle WE, Manne U.

Cancer. 2003 Dec 25;99(6):365-71.

20.

Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.

Nissim S, Idos GE, Wu B.

Pancreas. 2012 Nov;41(8):1195-205. doi: 10.1097/MPA.0b013e3182580fb4.

Supplemental Content

Support Center